Researchers in Leeds say PMR is underdiagnosed and undertreated in the north of England.

The list of medications covered by the Estonian Health Insurance Fund was expanded in January, with new additions including ...

Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript February 4, 2026 Novartis AG beats earnings expectations. Reported ...

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...

Researchers at the NIHR Leeds Biomedical Research Centre (BRC) and the University of Leeds have led an innovative new project studying how to bridge the gap between patients with PMR (Polymyalgia ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Editor's Note: The following contains spoilers for '28 Years Later: The Bone Temple'28 Years Later: The Bone Temple is finally here, and yes, it really is as good as you've heard it is. Director Nia ...

New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the disease progresses.

Kyle Donahue survived glioblastoma for five years after joining a clinical trial at Brigham and Women's Hospital. The trial used CAN-3110, an engineered herpes virus, to target and kill glioblastoma ...

Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure.

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...